<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="67079">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01835639</url>
  </required_header>
  <id_info>
    <org_study_id>12-009753</org_study_id>
    <secondary_id>K23DK093556</secondary_id>
    <nct_id>NCT01835639</nct_id>
  </id_info>
  <brief_title>Vitamin D Supplementation in Glomerular Disease</brief_title>
  <official_title>Pilot Study: Efficacy and Safety of Vitamin D Supplementation in Glomerular Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Philadelphia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>American Society of Nephrology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The NephCure Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital of Philadelphia</source>
  <oversight_info>
    <authority>United States: Data and Safety Monitoring Plan - Safety Officer</authority>
    <authority>United States: Institutional Review Board</authority>
    <authority>United States: Federal Government</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multi-site, pilot study will assess vitamin D supplementation in children and young
      adults with focal segmental glomerulosclerosis (FSGS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vitamin D deficiency has been linked to a variety of adverse health outcomes. Nephrotic
      patients have very low vitamin D levels, and the underlying mechanisms are not known.
      Furthermore, approaches to safely and effectively supplement vitamin D in these patients
      have not been established. The purpose of this research study is to learn if vitamin D
      supplementation is safe and effective in patients with focal segmental glomerulosclerosis
      (FSGS) and to also help establish the treatment guidelines. About 35 patients with FSGS,
      ages 5-30 years old, will take part in this study. Participants will be asked to take
      vitamin D supplements each day for 12 weeks and will have 3 study visits.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>To assess the efficacy of vitamin D supplementation, by the increase in total and free 25(OH)D levels.</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>To assess the safety of vitamin D supplementation, by serum Ionized calcium (ICal), Pi, and 25(OH)D, and urinary calcium excretion.</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>To assess the innate immune response, measured by changes in the induction of Human cathelicidin antimicrobial protein (hCAP) in human monocytes.</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess intra-renal inflammation, measured by changes in urinary Macrophage chemo-attractant protein 1 (MCP-1).</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess arterial stiffness, measured by changes in pulse wave velocity.</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Focal Segmental Glomerulosclerosis (FSGS)</condition>
  <arm_group>
    <arm_group_label>Vitamin D Supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cholecalciferol, 4000 IUs by mouth daily for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cholecalciferol, 4000 IUs by mouth daily for 12 weeks</intervention_name>
    <description>Supplements will be provided as oral capsules or chewable gummies.</description>
    <arm_group_label>Vitamin D Supplementation</arm_group_label>
    <other_name>Vitamin D</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or females, age 5-30 years

          -  Diagnosis of biopsy-proven FSGS

          -  Serum 25(OH)D level &lt;20 ng/ml and urine protein:creatinine ratio â‰¥0.5 at Screening
             Visit

          -  No new immuno-modulatory agent within prior 3 months of Screening Visit (not
             including corticosteroid therapy)

        Exclusion Criteria:

          -  Pregnancy

          -  estimated Glomerular Filtration Rate (eGFR) &lt;30 ml/min/1.73m2 at Screening Visit

          -  Serum phosphorus &gt; 5.5 mg/dl or hypercalcemia

          -  Chronic medical conditions or medications unrelated to the renal disease that may
             impact vitamin D status

          -  Known history of kidney stone(s)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michelle Denburg, MD, MSCE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Philadelphia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy York</last_name>
    <phone>267-648-3256</phone>
    <email>york@email.chop.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jonathan Savant</last_name>
    <phone>267-426-8386</phone>
    <email>savantj@email.chop.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nemours/Alfred I. duPont Hospital for Children</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Christopher LaRosa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North Shore-Long Island Jewish Health System</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Frank, RN</last_name>
      <phone>718-470-3493</phone>
      <email>Rfrank@ushs.edu</email>
    </contact>
    <investigator>
      <last_name>Christine Sethna, MD, EdM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy York</last_name>
      <phone>267-648-3256</phone>
      <email>york@email.chop.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jonathan Savant</last_name>
      <phone>267-426-8386</phone>
      <email>savantj@email.chop.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Michelle Denburg, MD, MSCE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Lawrence Holzman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 7, 2014</lastchanged_date>
  <firstreceived_date>April 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Focal segmental glomerulosclerosis</keyword>
  <keyword>FSGS</keyword>
  <keyword>Vitamin D</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Glomerulosclerosis, Focal Segmental</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
